[1] |
Anderson BO, Duggan C, Scheel JR. Resource-appropriate evidence-based strategies to improve breast cancer outcomes in low-and middle-income countries guided by the Breast Health Global Initiative and Global Breast Cancer Initiative[J]. J Surg Oncol, 2023, 128(6): 952-958.
|
[2] |
Fowler AM, Mankoff DA, Joe BN. Imaging neoadjuvant therapy response in breast cancer[J]. Radiology, 2017, 285(2): 358-375.
|
[3] |
邵志敏, 吴炅, 江泽飞, 等. 中国乳腺癌新辅助治疗专家共识(2022年版)[J]. 中国癌症杂志, 2022, 32(1): 80-89.
|
[4] |
Shepherd JH, Ballman K, Polley MYC, et al. CALGB 40603 (Alliance): long-term outcomes and genomic correlates of response and survival after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple-negative breast cancer[J]. J Clin Oncol, 2022, 40(12): 1323-1334.
|
[5] |
Sang Y, Zhou X, Chi W, et al. Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: a single-center retrospective study[J]. Front Oncol, 2022, 12: 984587.
|
[6] |
陈武臻, 黄建, 等. 中国可视化经皮穿刺乳腺组织定位导丝与定位标记夹临床实践指南(2022版)[J]. 中国实用外科杂志, 2022, 42(8): 850-857.
|
[7] |
中华医学会外科学分会乳腺外科学组. 可视化经皮穿刺乳腺组织定位标记夹临床应用专家共识与技术操作意见(2020)[J]. 中华外科杂志, 2020, 58(3): 165-169.
|
[8] |
沈俊杰, 王祥芝, 杨菊萍, 等. X线摄影联合导丝定位切除术在BI-RADS4类钙化中的应用[J]. 实用放射学杂志, 2021, 37(4): 575-578.
|
[9] |
宋颖, 欧阳汉, 叶枫, 等. MRI引导下乳腺病灶导丝定位活检术的临床应用[J]. 磁共振成像, 2021, 12(6): 92-96.
|
[10] |
王昭蕊, 裴静. 乳腺组织定位标记夹在乳腺外科中的应用[J]. 中华乳腺病杂志(电子版), 2020, 14(5): 312-316.
|
[11] |
Giani M, Tavella K, Renda I, et al. Prognostic role of tumor size reduction> 50% after neoadjuvant chemotherapy for breast cancer[J]. J Cancer Sci Clin Ther, 2022, 6: 349-357.
|
[12] |
郝军生, 李南林. 乳腺组织标记定位针在乳腺癌新辅助化疗后保乳手术中的应用[J]. 临床与病理杂志, 2020, 40(9):2312-2317.
|
[13] |
尤超, 周嘉音, 陶珂, 等, 基于影像组学评估乳腺癌新辅助治疗效果[J]. 中华放射学杂志, 2021, 55(11): 1226-1229.
|
[14] |
Song D, Man X, Jin M, et al. A decision-making supporting prediction method for breast cancer neoadjuvant chemotherapy[J]. Front Oncol, 2021, 10: 592556.
|
[15] |
Yim H, Ha T, Kang DK, et al. Change in microcalcifications onmammography after neoadj uvant chemotherapy in breast cancer patients:correlation with tumor response grade and comparison with lesion extent[J]. Acta Radiol, 2019, 60(2):131-139.
|
[16] |
Mistry KA, Thakur MH, Kembhavi SA. The effect of chemotherapy on the mammographic appearance of breast cancer and correlation with histopathology[J]. Br J Radiol, 2016. 89(1057): 20150479.
|
[17] |
肖勤, 顾雅佳. 影像学在评估乳腺癌新辅助化疗中反应的应用与进展[J]. 肿瘤影像学, 2020, 29(2): 65-72.
|
[18] |
白熠洲, 于俊平, 郭丽婧, 等. 乳腺癌新辅助治疗患者乳腺内病灶定位标记夹放置和取出的影响因素[J]. 解放军预防医学杂志, 2019, 37(11): 10-11.
|
[19] |
周毅, 蔡仕彬, 陈述政, 等. 超声造影联合标记标记夹定位在乳腺癌新辅助化疗后前哨淋巴结活检中的应用[J]. 浙江医学, 2020, 42(23): 2533-2537.
|
[20] |
魏建南, 郑爱秋, 曾圣光, 等. 乳腺钙化女性患者X线立体定位真空辅助旋切活检术后乳腺组织定位标记夹移位情况分析[J]. 山东医药, 2021, 61(14): 72-74.
|
[21] |
刘芳, 韩萍, Roman S. 乳腺可疑微钙化灶金属标记夹放置的筛选条件及近期移位的影响因素[J]. 中华放射学杂志, 2009, 43(5): 480-485.
|